TRAILR1/TNFRSF10A Biotinylated Antibody BAF347 from R&D Systems, a Bio-Techne Brand | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
R&D Systems, a Bio-Techne Brand for
TRAILR1/TNFRSF10A Biotinylated Antibody

R&D Systems, a Bio-Techne Brand's TRAILR1/TNFRSF10A Biotinylated Antibody is a Goat Polyclonal antibody. This antibody has been shown to work in applications such as: Western Blot. The TRAILR1/TNFRSF10A Biotinylated Antibody was generated using TNFRSF10A as the antigen and it reacts with Homo Sapiens, and Human.

Product Specs
ItemTRAILR1/TNFRSF10A Biotinylated Antibody
CompanyR&D Systems, a Bio-Techne Brand
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberBAF347
ApplicationsWestern Blot
Quantity50 ug
HostGoat
Conjugate/TagBiotin
IsotypeIgG
ReactivityHuman
TargetTRAILR1/TNFRSF10A
FormatLyophilized from a 0.2 µm filtered solution in PBS with BSA as a carrier protein
ClonalityPolyclonal
ImmunogenS. frugiperda insect ovarian cell line Sf 21-derived recombinant human TRAIL R1/TNFRSF10A, Ala24-Asn239, Accession # AAC51226
Antibody TypePrimary Antibodies
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution
Brand/TrademarkR&D Systems, a Bio-Techne Brand
PurityAntigen Affinity-purified
ConcentrationLYOPH
NCBI Full Gene NameTNF receptor superfamily member 10a
NCBI Gene AliasesAPO2, CD261, DR4, TRAILR-1, TRAILR1

Specifications/Features

Available conjugates: Biotin

Specificity: Detects human TRAIL R1/TNFRSF10A in Western blots. In Western blots, approximately 10% cross-reactivity with recombinant human (rh) TRAIL R2 is observed and no cross-reactivity with rhTRAIL R3 and rhTRAIL R4 is observed

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatmentThe Journal of pharmacology and experimental therapeuticsMarch 1, 2014Gatti L, Cossa G, Tinelli S, Carenini N, Arrighetti N, Pennati M, Cominetti D, De Cesare M, Zunino F, Zaffaroni N, et al.

(2) Rapid and profound potentiation of Apo2L/TRAIL-mediated cytotoxicity and apoptosis in thoracic cancer cells by the histone deacetylase inhibitor Trichostatin A: the essential role of the mitochondria-mediated caspase activation cascadeApoptosis : an international journal on programmed cell deathJanuary 1, 2007Reddy RM, Yeow WS, Chua A, Nguyen DM, Baras A, Ziauddin MF, Shamimi-Noori SM, Maxhimer JB, Schrump DS, Nguyen DM.

(3) Enhancement of Apo2L/TRAIL-mediated cytotoxicity in esophageal cancer cells by cisplatinMolecular cancer therapeuticsDecember 1, 2006Tsai WS, Yeow WS, Chua A, Reddy RM, Nguyen DM, Schrump DS, Nguyen DM.

(4) Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Burkitt's lymphoma cell linesBritish journal of haematologyJuly 1, 2003Mouzakiti A, Packham G.

Be the First to Write a Review!